Skip to content
Prices checked against public provider pages Current, monitored and future routes kept separate Prescription medicines require clinical assessment

Wegovy pill 1.5mg: starting dose guide UK

1.5mg is the opening strength in the UK Wegovy pill dose ladder. The public product information lists it as the first monthly stage before 4mg, 9mg and 25mg. It is available on private prescription, following a clinician’s assessment.

1.5mg | 4mg | 9mg | 25mg

Where 1.5mg fits in the Wegovy pill route

Wegovy tablets contain semaglutide. The UK patient leaflet sets out a stepped treatment schedule, beginning with one 1.5mg tablet daily for the first month. The later strengths are part of the product schedule, not interchangeable products to choose between on price alone.

The lowest strength is therefore useful to compare as a starting-month cost. It does not indicate what a prescriber will recommend after assessment, how long treatment will continue, or whether Wegovy is suitable for an individual.

Availability and price checks

1.5mg and 4mg Wegovy tablets have been available privately in the UK since 6 July 2026. Provider prices can include different consultation, delivery or subscription terms, so the standard-price table keeps those additions separate. Check the provider page before ordering, particularly where a first order is presented differently from a renewal.

Compare current Wegovy pill providers and published standard prices.

See the current Wegovy pill availability overview.

Taking the tablet

The patient leaflet gives the administration instructions for every Wegovy tablet strength: it is taken after a fasting period, swallowed whole with a small amount of water, then followed by a wait before food, other drinks or oral medicines. The exact instructions matter for absorption, so use the leaflet supplied with the medicine and the prescriber’s advice rather than changing the routine yourself.

Read the Wegovy pill food-timing guide for a plain-English summary and a link to the official leaflet.

Side effects and follow-up

Nausea, vomiting, diarrhoea, constipation and stomach pain are listed among the very common side effects in the patient leaflet. A medicine page cannot judge whether a symptom is expected in an individual case. Speak to the prescribing service, pharmacist or GP if symptoms are troublesome, persistent, or make it difficult to keep fluids down.

Urgent medical advice is needed for severe or persistent abdominal pain, signs of a serious allergic reaction, or sudden or worsening eyesight. The official leaflet also explains how suspected side effects can be reported through the MHRA Yellow Card scheme.

Official information

Read the Wegovy tablets patient information leaflet before treatment. It contains the full approved dose schedule, safety information and instructions for use.

Related guides

General information only. Wegovy is a prescription-only medicine. A prescriber decides suitability, dose and monitoring.